TP53-independent Function of miR-34a via HDAC1 and p21CIP1/WAF1
Authors:
- Paul LammersPLPaul Lammers
- Chris J TorranceCTChris J Torrance
- Andreas G BaderABAndreas G Bader
Open Access
- 1 September 2013
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 21 (9) , 1678-1686
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- MicroRNA-34a Modulates MDM4 Expression via a Target Site in the Open Reading FramePLOS ONE, 2012
- Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivoLeukemia, 2012
- RETRACTED: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma DevelopmentCancer Cell, 2010
- Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34Cancer Research, 2010
- miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancerCarcinogenesis, 2009
- Normalization of microRNA expression levels in quantitative RT-PCR assays: Identification of suitable reference RNA targets in normal and cancerous human solid tissuesRNA, 2008
- Thelet-7microRNA reduces tumor growth in mouse models of lung cancerCell Cycle, 2008
- Differential Regulation of microRNAs by p53 Revealed by Massively Parallel Sequencing: miR-34a is a p53 Target That Induces Apoptosis and G1-arrestCell Cycle, 2007
- Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancersProceedings of the National Academy of Sciences of the United States of America, 2004
- Amplification of a gene encoding a p53-associated protein in human sarcomasNature, 1992